ResMed | RMD - Stock


ResMed reported $911.88M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Ansell USD 584.7M 126.8M Jun/2025
Artivion USD 97.99M 5.57M Mar/2026
AtriCure USD 81.14M 2.65M Mar/2026
Baxter International USD 2.32B 84M Mar/2026
Cochlear AUD 499.4M 107.8M Jun/2025
Cooper Companies USD 846M 35M Sep/2025
CSL USD 6.47B 327M Jun/2025
Dexcom USD 693.6M 64.5M Mar/2026
Edwards Lifesciences USD 1.12B 7.2M Mar/2026
Fisher Paykel Healthcare NZD 358.9M 67.1M Jun/2022
Globus Medical USD 772.6M 13.32M Mar/2026
Haemonetics USD 306.37M 14.82M Mar/2026
Idexx Laboratories USD 382.4M 4.64M Mar/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 462.5M 9.9M Mar/2026
Integra LifeSciences USD 495.04M 2.3M Mar/2026
Intuitive Surgical USD 1.95B 105.1M Mar/2026
Masimo USD 400M 61.4M Mar/2026
Medtronic USD 6.31B 153M Dec/2025
Philips EUR 2.87B 390M Dec/2025
Ramsay Health Care AUD 404.4M 25M Jun/2025
ResMed USD 911.88M 10.17M Mar/2026
Sigma Healthcare AUD 324.85M 25.65M Jan/2023
Sonic Healthcare AUD 208.83M 3.83M Jun/2024
Steris USD 673.5M 15M Dec/2025
Teleflex USD 380.86M 23.53M Mar/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026